Impact of wildfires on Alzheimer's disease and related dementias
Short and long-term consequences of wildfires for Alzheimer's disease and related dementias
This study is looking at how breathing in smoke and tiny particles from wildfires might affect brain health, especially for people who could be more at risk for memory problems or Alzheimer's, and it’s for anyone interested in understanding how living near wildfires could impact cognitive health over time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11079633 on NIH RePORTER |
What this research studies
This research investigates how exposure to particulate matter from wildfires may increase the risk of mild cognitive impairment and Alzheimer's disease. It aims to identify factors that make certain individuals or communities more susceptible to these risks. By analyzing data from various sources, including weather and satellite data, the study seeks to understand the long-term effects of living near wildfire areas on cognitive health. The research employs advanced machine learning techniques to model exposure levels and their potential impacts.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living in areas prone to wildfires, particularly those with a family history of Alzheimer's disease or related dementias.
Not a fit: Patients who do not live in wildfire-prone areas or those without any risk factors for Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and prevention strategies for Alzheimer's disease and related dementias in populations affected by wildfires.
How similar studies have performed: Previous research has indicated a correlation between environmental factors and cognitive decline, suggesting that this approach may yield valuable insights.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Casey, Joan a — University of Washington
- Study coordinator: Casey, Joan a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.